TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Claimsfiler
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

Cytokinetics faces a securities class action lawsuit alleging failure to disclose material information about its New Drug Application for aficamten, with stock price dropping after FDA-related disclosures.

Insights
CYTK   negative

Company is facing a class action lawsuit for allegedly withholding material information about its drug application, which led to a stock price decline and potential legal consequences